panCELLa is a Toronto based biotech company with a focus on gene editing and cellular therapies. panCELLa seeks to provide absolute control of deregulated cell proliferation and our innovative technology is based on creating a tight link between a drug inducible suicide gene and a gene essential to cell division. This mechanism enables dividing, potentially malignant cells to be eliminated at will before or after transplantation into patients. panCELLa is seeking out licensing opportunities for FailSafe technology as well as partners for collaboration.

panCELLa Inc. Logo



Event details

Date: June 13 - 16, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


26 in total